$4.70
0.214.68%
At Close: -
$4.47
-0.23-4.89%
After Hours: 4:32 PM EDT
15 minutes delayed
MaxCyte
MXCTNASDAQ
MaxCyte (NASDAQ:MXCT) Stock Quotes, Forecast and News Summary
MaxCyte Stock (NASDAQ: MXCT) stock price, news, charts, stock research, profile.
| Open | $4.55 |
| Close | $4.70 |
| Volume / Avg. | 371.19K / 563.16K |
| Day Range | 4.51 - 4.71 |
| 52 Wk Range | 2.45 - 5.55 |
| Market Cap | $467.31M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 61 |
| Short Interest | 3.92% |
| Days to Cover | 4.81 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About MaxCyte Inc
Sector
Health Care
Industry
Life Sciences Tools & Services
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technolo...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy MaxCyte (MXCT) stock?
You can purchase shares of MaxCyte (NASDAQ:MXCT) through any online brokerage.
Who are MaxCyte (MXCT) competitors?
Other companies in MaxCyte’s space includes: Harvard Bioscience (NASDAQ:HBIO), 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS) and Lifecore Biomedical (NASDAQ:LFCR).
What is the target price for MaxCyte (MXCT) stock?
There is no analysis for MaxCyte.
What is the forecast for MaxCyte (MXCT) stock?
MaxCyte has a consensus price target of $11.00.
Current stock price for MaxCyte (MXCT)?
The stock price for MaxCyte (NASDAQ: MXCT) is $4.47 last updated July 15, 2024 at 4:32 PM EDT.
Does MaxCyte (MXCT) pay a dividend?
There are no upcoming dividends for MaxCyte.
When is MaxCyte (NASDAQ:MXCT) reporting earnings?
MaxCyte’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is MaxCyte (MXCT) going to split?
There is no upcoming split for MaxCyte.
What sector and industry does MaxCyte (MXCT) operate in?
MaxCyte is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.